2024.09.11
Publisher：
times
On the afternoon of September 6, Huayi ushered in an important milestone. The celebration was held for the first shipment of Bisoprolol Fumarate Tablets (licensed by Zhejiang Brother Pharmaceutical Co., Ltd.), which was developed and manufactured in Huayi. This moment marks another achievement for Huayi in the field of drug R&D and production, and also shows the close cooperation relationship with Zhejiang Brother.
At the celebration ceremony, Mr. Zhou, General manager of Domestic Marketing Center of Huayi, warmly welcomed the guests present and thanked all the team members involved in the project.
And then, Mr. Shen, Head of the Zhejiang Brother, made a speech: "I sincerely thank Huayi for its professionalism and efficiency in the product R&D and production process, which promotes our mutual progress and growth. We also look forward to having closer cooperation with Huayi in the future."
Finally, Gao Yu, the Chairman of Huayi, made a speech: "The R&D and production of drugs is related to people's health and carries an extremely heavy responsibility. The successful shipment of this drug product is not only a test of our professional ability, but also a strong proof of our enterprise’s mission and responsibility. Here, I would like to express my sincere thanks to all the employees who have worked hard. At the same time, we also extend our deepest thanks to Zhejiang Brother who has always given us trust and support!"
Adhering to the principle of responsibility first and excellence in service, Huayi has demonstrated professional competence and quality throughout R&D and production and consistently provided high quality, high efficiency and convenient services for partners, and is looking forward to creating unlimited possibilities with more partners.
